Summary

germandavid56 Users

  • Safety of Ocrelizumab inside Individuals With Relapsing and Primary Intensifying Ms.
Offline Offline
Posts:
0 (N/A per day)
Age:
N/A
Date Registered:
Today at 00:30:44
Local Time:
2025-07-01, 09:55:00
Last Active:
Today at 02:20:04
Signature:
Abandonment of treatment, a major cause of treatment failure in low- and middle-income countries like India, is particularly high during the diagnosti